About: Lorcainide

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Lorcainide (Lorcainide hydrochloride) is a Class 1c antiarrhythmic agent that is used to help restore normal heart rhythm and conduction in patients with premature ventricular contractions, ventricular tachycardiac and Wolff–Parkinson–White syndrome. Lorcainide was developed by Janssen Pharmaceutica (Belgium) in 1968 under the commercial name Remivox and is designated by code numbers R-15889 or Ro 13-1042/001. It has a half-life of 8.9 +- 2.3 hrs which may be prolonged to 66 hrs in people with cardiac disease.

Property	Value
dbo:abstract	Lorcainide (Lorcainide hydrochloride) is a Class 1c antiarrhythmic agent that is used to help restore normal heart rhythm and conduction in patients with premature ventricular contractions, ventricular tachycardiac and Wolff–Parkinson–White syndrome. Lorcainide was developed by Janssen Pharmaceutica (Belgium) in 1968 under the commercial name Remivox and is designated by code numbers R-15889 or Ro 13-1042/001. It has a half-life of 8.9 +- 2.3 hrs which may be prolonged to 66 hrs in people with cardiac disease. (en)
dbo:casNumber	59729-31-6
dbo:chEMBL	87543
dbo:fdaUniiCode	KGJ2T0N7IQ
dbo:kegg	D08020
dbo:pubchem	42884
dbo:thumbnail	wiki-commons:Special:FilePath/Lorcainide.svg?width=300
dbo:wikiPageID	7013320 (xsd:integer)
dbo:wikiPageLength	10846 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1115523532 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cardiac_cycle dbr:Pre-excitation_syndrome dbr:Bradycardia dbr:Antiarrhythmic_agent dbr:Hydrobromic_acid dbr:Ventricular_fibrillation dbr:Ventricular_tachycardia dbr:Cardiac_dysrhythmia dbc:Chloroarenes dbc:Isopropyl_compounds dbc:Piperidines dbr:PR_interval dbr:Therapeutic_index dbr:Action_potential dbr:4-Chloroaniline dbc:Janssen_Pharmaceutica dbc:Sodium_channel_blockers dbr:ECG dbr:Anesthetic dbr:Pacemaker dbr:QRS_complex dbc:Acetanilides dbr:Atrioventricular_node dbr:Ischemia dbr:Janssen_Pharmaceutica dbr:Hypoxia_(medical) dbr:Atrial_fibrillation dbc:Antiarrhythmic_agents dbc:Belgian_inventions dbr:Syncope_(medicine) dbr:Tachycardia dbr:Ectopic_pacemaker dbr:Efficacy dbr:Ejection_fraction dbr:Sodium_borohydride dbr:Nav1.5 dbr:Wolff–Parkinson–White_syndrome dbr:Sinus_node dbr:Palpitations dbr:Premature_ventricular_contractions dbr:Proarrhythmic dbr:Antiarrhythmic_agents dbr:Isopropyl_bromide dbr:File:Lorcainide_synthesis.svg dbr:Phenacetyl_chloride dbr:Wikt:anil
dbp:atcPrefix	1.0
dbp:atcSuffix	BC07 (en)
dbp:c	22 (xsd:integer)
dbp:casNumber	59729 (xsd:integer)
dbp:chembl	87543 (xsd:integer)
dbp:chemspiderid	39116 (xsd:integer)
dbp:cl	1 (xsd:integer)
dbp:eliminationHalfLife	14.300000 (xsd:double)
dbp:h	27 (xsd:integer)
dbp:iupacName	N--N--2-phenylacetamide (en)
dbp:kegg	D08020 (en)
dbp:n	2 (xsd:integer)
dbp:o	1 (xsd:integer)
dbp:proteinBound	78 (xsd:integer)
dbp:pubchem	42884 (xsd:integer)
dbp:smiles	Clc3ccccc3 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	XHOJAWVAWFHGHL-UHFFFAOYSA-N (en)
dbp:unii	KGJ2T0N7IQ (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	462093837 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Antiarrhythmic_agents
dcterms:subject	dbc:Chloroarenes dbc:Isopropyl_compounds dbc:Piperidines dbc:Janssen_Pharmaceutica dbc:Sodium_channel_blockers dbc:Acetanilides dbc:Antiarrhythmic_agents dbc:Belgian_inventions
gold:hypernym	dbr:Class
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatBelgianInventions yago:WikicatMolecularFormulas yago:Ability105616246 yago:Abstraction100002137 yago:Acetamide114711197 yago:Amide114724264 yago:Chemical114806838 yago:Cognition100023271 yago:Communication100033020 yago:Compound114818238 yago:Creativity105624700 yago:Formula106816935 yago:Invention105633385 yago:Material114580897 yago:Matter100020827 yago:Message106598915 yago:MolecularFormula106817173 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:PsychologicalFeature100023100 yago:Relation100031921 dbo:Drug yago:Statement106722453 yago:Substance100019613 yago:WikicatAcetamides umbel-rc:DrugProduct
rdfs:comment	Lorcainide (Lorcainide hydrochloride) is a Class 1c antiarrhythmic agent that is used to help restore normal heart rhythm and conduction in patients with premature ventricular contractions, ventricular tachycardiac and Wolff–Parkinson–White syndrome. Lorcainide was developed by Janssen Pharmaceutica (Belgium) in 1968 under the commercial name Remivox and is designated by code numbers R-15889 or Ro 13-1042/001. It has a half-life of 8.9 +- 2.3 hrs which may be prolonged to 66 hrs in people with cardiac disease. (en)
rdfs:label	Lorcainide (en)
owl:sameAs	freebase:Lorcainide yago-res:Lorcainide wikidata:Lorcainide dbpedia-sh:Lorcainide dbpedia-sr:Lorcainide https://global.dbpedia.org/id/4rDun
prov:wasDerivedFrom	wikipedia-en:Lorcainide?oldid=1115523532&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Lorcainide.svg wiki-commons:Special:FilePath/Lorcainide_synthesis.svg
foaf:isPrimaryTopicOf	wikipedia-en:Lorcainide
is dbo:wikiPageRedirects of	dbr:C22H27ClN2O dbr:ATC_code_C01BC07 dbr:ATCvet_code_QC01BC07
is dbo:wikiPageWikiLink of	dbr:List_of_compounds_with_carbon_number_22 dbr:Proarrhythmic_agent dbr:C22H27ClN2O dbr:ATC_code_C01BC07 dbr:ATCvet_code_QC01BC07 dbr:Janssen_Pharmaceuticals dbr:ATC_code_C01 dbr:Phenylacetic_acid dbr:List_of_drugs:_Lo
is foaf:primaryTopic of	wikipedia-en:Lorcainide